| Changes to trial information |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Funding Source |
FundingSources List |
24/06/2026 |
Write the actual name of PI |
Self funded study, Faculty of Nursing Fayoum University, Fayoum, 63514, Egypt, Self Funded, |
Amany Ibrahim Abdalla, Faculty of Nursing Fayoum University, Fayoum, 63514, Egypt, Self Funded, |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
IPD description |
24/06/2026 |
The reporting section has been updated to include the required IPD sharing statement and to clarify the availability of summary results in accordance with registry requirements. |
Individual participant data includes anonymized demographic characteristics, preoperative anxiety scores (mYPAS), pediatric symptom scores (PSC), and parental satisfaction scores (PSQ-18) collected during the study |
De-identified individual participant data will include anonymized demographic characteristics, preoperative anxiety scores measured by the modified Yale Preoperative Anxiety Scale (mYPAS), pediatric symptom/checklist scores, and parental satisfaction scores measured by the PSQ-18, as collected during the study. |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
IPD-Sharing time frame |
24/06/2026 |
The reporting section has been updated to include the required IPD sharing statement and to clarify the availability of summary results in accordance with registry requirements. |
After publication of study results (e.g., 6–12 months after publication) or upon reasonable request |
De-identified data will be available after publication of the main study results, approximately 6–12 months after publication, or upon reasonable request, subject to institutional approval. |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
Key access criteria |
24/06/2026 |
The reporting section has been updated to include the required IPD sharing statement and to clarify the availability of summary results in accordance with registry requirements. |
De-identified data available upon reasonable request from qualified researchers with ethical approval; data use subject to institutional approval and confidentiality requirements |
De-identified data will be made available upon reasonable request to qualified researchers who provide a scientifically valid proposal and evidence of ethical approval. Data access will be subject to institutional approval, confidentiality requirements, and a signed data use agreement. |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
Results Available |
17/07/2026 |
The Reporting section was updated to include baseline characteristics, participant flow, adverse-event information, and primary and secondary outcome results in response to the trial reviewer’s comments. |
No |
Yes |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
Result Summary Pdf file1 |
17/07/2026 |
The Reporting section was updated to include baseline characteristics, participant flow, adverse-event information, and primary and secondary outcome results in response to the trial reviewer’s comments. |
|
41516_28676_1045.pdf |